Eric Dane’s death on Feb. 19, 2026, felt personal for many viewers. He had been a familiar face in their living rooms for nearly four decades.
His long television career began with his debut as Tad Pogue on an episode of Saved by The Bell in 1991. From there, Dane became a steady presence on-screen, with audiences coming to know versions of him that showed up on television week after week, even if they never knew him personally.
The charming “McSteamy” on Grey’s Anatomy, the complicated Cal Jacobs on Euphoria, or the steady presence of other supporting roles that helped his recognition.
Dane’s passing followed a public journey with amyotrophic lateral sclerosis (ALS), often called Lou Gehrig’s disease, is a neurodegenerative condition that affects how nerve cells communicate with your muscles.
Over time, ALS weakens voluntary muscles, often beginning with subtle changes in strength or coordination before advancing to difficulties with speaking, walking, swallowing, and breathing.
News of his death came as a shock, especially fans who followed his journey in the months after his diagnosis. One of them, Trinite Drew, a senior education student, reflected on his death.
“I was absolutely shocked and his death really had an impact on me not just because he was my favorite character on a tv show but his diagnosis was only 10 months ago,” she says.
There is currently no known cure for ALS, and available treatments focus on slowing the progression and managing symptoms.
Dane shared his diagnosis with well-known individuals like physicist Stephen Hawking and baseball legend Lou Gehrig, both of whom lived with ALS and helped bring greater awareness to the disease.
Drew continued to say, “It really shocked me that he died that quick and his symptoms were changing his body so fast.”
By choosing to share his diagnosis and speak about his experience, Dane allowed the public to not only see his work as an actor, but also the realities of living with a long-term, life-altering illness.

Before his diagnosis, Dane’s career was built on years of hard work and persistence.
After early guest appearances in the 1990s, like roles on The Wonder Years and Roseanne, he slowly climbed the ladder from one-off guest parts to bigger, ongoing roles.
His role as Dr. Mark Sloan on Grey’s Anatomy marked a turning point, establishing Dane as a recognizable television star.
As “McSteamy,” he became associated with one of the most-watched medical drama of its time, which in turn created opportunities for Dane in both television and film.
Following Grey’s Anatomy, Dane took on leading roles like Captain Tom Chandler on The Last Ship, and appeared in films such as Redeeming Love, Bad Boys: Ride or Die, and more, showing his range between drama, action, and character stories.
These projects kept him regularly on screen, big and small, keeping him active in the industry.
During the period when he was living with ALS, Dane continued to work in acting projects while dealing with the progression of his symptoms.
He reprised his role as Cal Jacobs in the third season of Euphoria, set to premiere April 26, 2026, appeared in the Prime Video series Countdown, and had a guest role in the TV show Brilliant Minds where he played a character dealing with ALS.
Dane adapted to changes in mobility and speech, working with the limits of his condition while continuing to act, in fact vowing to “ride this till the wheels fall off.”
Even as Dane faced ALS, he stayed committed to his work, showing others how determined he was.
“His choice to keep going while living with ALS shows that a disease doesn’t make you. You don’t have to let a disease take over your life because life keeps moving,” said Trinidy Davis, a sophomore journalism and mass communication student.
Dane’s openness about ALS helped spotlight the need for more research and support, sparking conversations that will continue after his passing.
Eric Dane will be remembered as the actor who brought heart to every role, from early TV spots to his final appearances, leaving a legacy of talent that connects his screen work to greater awareness of ALS.
